Who are Desflurane with remifentanil's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/desflurane-with-remifentanil.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Desflurane with remifentanil — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Desflurane with remifentanil (Desflurane with remifentanil) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Volatile anesthetic with opioid analgesic. Area: Anesthesiology.

marketed Volatile anesthetic with opioid analgesic GABA receptors (desflurane); mu-opioid receptors (remifentanil) Anesthesiology Small molecule Live · refreshed every 30 min

Target snapshot

Desflurane with remifentanil (Desflurane with remifentanil) — Chung-Ang University Hosptial, Chung-Ang University College of Medicine. Desflurane is a volatile anesthetic that depresses the central nervous system, while remifentanil is an opioid agonist that provides analgesia and enhances anesthesia.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Desflurane with remifentanil TARGET	Desflurane with remifentanil	Chung-Ang University Hosptial, Chung-Ang University College of Medicine	marketed	Volatile anesthetic with opioid analgesic	GABA receptors (desflurane); mu-opioid receptors (remifentanil)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Volatile anesthetic with opioid analgesic class)

Chung-Ang University Hosptial, Chung-Ang University College of Medicine · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Desflurane with remifentanil — Competitive Intelligence Brief. https://druglandscape.com/ci/desflurane-with-remifentanil. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab